Brief: Nymox Receives Deficiency Letter From Nasdaq
14/07/2022 20:01
Nymox Pharmaceutical Corp NYMX.O :
* NYMOX RECEIVES DEFICIENCY LETTER FROM NASDAQ
Source text for Eikon: ID:nGNXbPW0ff
Further company coverage: NYMX.O
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba